Téléchargement | - Voir la version finale : Programmable attenuation of antigenic sensitivity for a nanobody-based EGFR chimeric antigen receptor through hinge domain truncation (PDF, 9.3 Mio)
- Voir les données supplémentaires : Programmable attenuation of antigenic sensitivity for a nanobody-based EGFR chimeric antigen receptor through hinge domain truncation (PDF, 6.3 Mio)
|
---|
DOI | Trouver le DOI : https://doi.org/10.3389/fimmu.2022.864868 |
---|
Auteur | Rechercher : McComb, Scott1Identifiant ORCID : https://orcid.org/0000-0002-4616-7864; Rechercher : Nguyen, Tina1; Rechercher : Shepherd, Alex1; Rechercher : Henry, Kevin A.1; Rechercher : Bloemberg, Darin1; Rechercher : Marcil, Anne1; Rechercher : Maclean, Susanne1; Rechercher : Zafer, Ahmed1; Rechercher : Gilbert, Rénald1; Rechercher : Gadoury, Christine1; Rechercher : Pon, Robert A.1; Rechercher : Sulea, Traian1; Rechercher : Zhu, Qin1; Rechercher : Weeratna, Risini D.1 |
---|
Affiliation | - Conseil national de recherches du Canada. Thérapeutique en santé humaine
|
---|
Format | Texte, Article |
---|
Sujet | cellular immunotherapy; EGFR; CAR optimization; CAR-T; hinge domain; cancer selectivity; cell therapy |
---|
Résumé | Epidermal growth factor family receptor (EGFR) is commonly overexpressed in many solid tumors and an attractive target for chimeric antigen receptor (CAR)-T therapy, but as EGFR is also expressed at lower levels in healthy tissues a therapeutic strategy must balance antigenic responsiveness against the risk of on-target off-tumor toxicity. Herein, we identify several camelid single-domain antibodies (also known as nanobodies) that are effective EGFR targeting moieties for CARs (EGFR-sdCARs) with very strong reactivity to EGFR-high and EGFR-low target cells. As a strategy to attenuate their potent antigenic sensitivity, we performed progressive truncation of the human CD8 hinge commonly used as a spacer domain in many CAR constructs. Single amino acid hinge-domain truncation progressively decreased both EGFR-sdCAR-Jurkat cell binding to EGFR-expressing targets and expression of the CD69 activation marker. Attenuated signaling in hinge-truncated EGFR-sdCAR constructs increased selectivity for antigen-dense EGFR-overexpressing cells over an EGFR-low tumor cell line or healthy donor derived EGFR-positive fibroblasts. We also provide evidence that epitope location is critical for determining hinge-domain requirement for CARs, as hinge truncation similarly decreased antigenic sensitivity of a membrane-proximal epitope targeting HER2-CAR but not a membrane-distal EGFRvIII-specific CAR. Hinge-modified EGFR-sdCAR cells showed clear functional attenuation in Jurkat-CAR-T cells and primary human CAR-T cells from multiple donors in vitro and in vivo. Overall, these results indicate that hinge length tuning provides a programmable strategy for throttling antigenic sensitivity in CARs targeting membrane-proximal epitopes, and could be employed for CAR-optimization and improved tumor selectivity. |
---|
Date de publication | 2022-07-22 |
---|
Maison d’édition | Frontiers Media |
---|
Licence | |
---|
Dans | |
---|
Complété par | |
---|
Langue | anglais |
---|
Publications évaluées par des pairs | Oui |
---|
Exporter la notice | Exporter en format RIS |
---|
Signaler une correction | Signaler une correction (s'ouvre dans un nouvel onglet) |
---|
Identificateur de l’enregistrement | 1d2bba96-61ea-4f41-8903-5ff249e3a8af |
---|
Enregistrement créé | 2023-04-11 |
---|
Enregistrement modifié | 2023-04-19 |
---|